For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not cost-effective at current pricing, new research shows.

For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, ...

Life expectancy in the United States increased in 2023, reaching 78.4 years, while drug overdose mortality decreased from 2022 to 2023.

(HealthDay News) — Health span-lifespan gaps, resulting from health-adjusted life expectancy lagging behind longevity gains, are growing worldwide, with women exhibiting a larger gap than men, ...

More men with limited life expectancy and certain localized prostate cancers have received definitive treatment over the past ...

In addition, ranking in terms of health-adjusted life expectancy, which estimates the average number of years an individual lives in good health, is projected to fall from 80 to 108. Despite the ...

Life expectancy in 2023 rose 0.9 years to 78.4 while the overall mortality rate adjusted for age declined 6%. Death rates ...

"Life expectancy in the U.S. last year made an unusually sharp increase as deaths from most major causes declined, according ...

The COVID-19 pandemic triggered a massive surge in mortality in the U.S., resulting in reduced life expectancy. But today ... rebounds in 2022 and 2023 are thanks to declines in the age-adjusted death ...

The death rate for Covid-19 – about 12 deaths for every 100,000 people in 2023, when adjusted ... and Health. He did not review the new CDC data but has extensively researched life expectancy ...

Murphy, from the National Center for Health Statistics ... an increase of 0.9 years in life expectancy for the US population, reaching 78.4 years in 2023. The age-adjusted death rate decreased ...

nearly double the overall age-adjusted rate. Lowering deaths from causes like this, which disproportionately impact younger age groups, can significantly boost life expectancy. The death rate from ...